Our Team

Tom Casdagli

Board Member, MVM Partners

BSc(Hons) Building Engineering and Management

About Tom

Thomas joined MVM Partners in 2002. Before joining MVM, he worked at PricewaterhouseCoopers’ Private Equity and Venture Capital practice. Thomas has an MBioch in Molecular and Cellular Biochemistry from Oxford University.

Thomas is a member of the boards of eXmoor Pharma, icotec AG and eZono GmbH. He was previously a director of Valneva SE (EPA: VLA), Alliance Pharma plc (AIM:APH), Lombard Medical Technologies plc (NASDAQ:EVAR), Heptares Ltd (acquired by Sosei Group Corporation), Avantium BV (AMS:AVTX), Onbone Oy, and Xention Pharma.

Let’s Accelerate Your Therapy Together

Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.